Maze Therapeutics, Inc.
MAZE
$14.28
$0.977.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.72% | -10.84% | -19.50% | -117.80% | 527.94% |
| Total Depreciation and Amortization | -5.12% | -2.98% | -10.53% | -7.73% | -10.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.12% | -25.60% | -10.02% | 121.15% | -65.53% |
| Change in Net Operating Assets | 27.16% | -238.22% | 119.71% | -315.40% | 875.50% |
| Cash from Operations | -1.82% | -31.46% | 3.24% | -116.00% | 718.88% |
| Capital Expenditure | -31.44% | 50.58% | -487.38% | 35.63% | 42.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.44% | 50.58% | -487.38% | 35.63% | 42.65% |
| Total Debt Issued | -- | -- | -- | -100.00% | -98.93% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.52% | 202,880.95% | -72.12% | 186.08% | -78.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 15.82% | 75.00% | -1,191.30% | -- |
| Cash from Financing | -99.52% | 81.29% | 3,368.00% | -1,496.10% | -99.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.58% | 106.68% | 285.42% | -117.55% | 16,667.86% |